How Signet Jewelers Survived Q1
Signet Jewelers shares retreated even after it released better than expected fiscal first-quarter financial results before the markets opened on Thursday.
All Work
Chris Lange
Campbell Soup Opens Up a Can on Q1 Earnings
Campbell Soup reported better than expected fiscal third-quarter financial results before the markets opened on Tuesday.
Why Merrill Lynch Has High Hopes for Cronos
Cronos shares popped on Wednesday after Merrill Lynch released a very positive report. This is not something that happens every day, but the brokerage firm issued a double upgrade with very significant upside.
Is InflaRx Sunk by a Midstage Skin Condition Study?
InflaRx shares were destroyed on Wednesday after the firm announced results from its midstage trial in patients suffering from moderate to severe hidradenitis suppurativa.
How ReWalk’s Exo-Suit Is Breaking the Mold for Stroke Survivors
ReWalk Robotics shares absolutely exploded on Wednesday on news that the FDA has cleared the firm's ReStore soft exo-suit system for sale to rehabilitation centers across the United States.
How China Propped Up Ambarella Earnings
Ambarella shares got a boost from a positive earnings surprise and better than expected revenue guidance.
American Eagle Outfitters Earnings Make the Case Against Recession
While some retailers are acting as if they face a recession, American Eagle Outfitters seems to be bucking this trend after its fiscal first-quarter earnings report.
Why Salseforce Is Reporting a Record Q1
Salesforce released its fiscal first quarter after the markets closed on Tuesday. The firm said that it had $0.93 in earnings per share (EPS) and $3.74 billion in revenue, compared with consensus estimates that…
Are Analysts Overly Positive on Uber and Lyft?
The quiet period for Uber is officially over and analysts are jumping all over themselves to issue calls on the ride-sharing firm. Lyft also saw some action from analysts on Tuesday as well.
What to Expect When Salesforce Reports After the Close
Salesforce is scheduled to release its fiscal first-quarter earnings after the markets close on Tuesday.
What Comes Next for Box?
Shares of Box retreated after the cloud services provider reported its most recent quarterly results.
Is FedEx Actually in Trouble With China?
FedEx shares saw a bump on Tuesday even though a recent analyst report suggested that the package delivery firm could be hurt by the trade war with China.
Are Shareholders Getting Enough in the Cypress Semiconductor Buyout?
Cypress Semiconductor shares hit a multiyear high on Monday after the firm announced that it would be acquired by Infineon.
Why Genocea’s Neoantigen Treatment Is Such a Big Hit at ASCO
Here is why Genocea Biosciences is one of the big winners from the annual meeting of the American Society of Clinical Oncology (ASCO).
Can Amazon Deliver 10 Million Items in One Day?
Amazon.com is in the midst of upgrading its Prime membership, and that means now roughly 10 million items qualify for one-day delivery.
Why NABE Thinks a Recession Is Off the Menu in 2019
The National Association for Business Economics released its survey for the month of May, and despite overarching concerns about recession and trade wars the panel saw a favorable outlook in the short term.
Beyond Meat, Campbell Soup, GameStop, Salesforce and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Beyond Meat, GameStop, Salesforce and some of the other most anticipated earnings reports expected this week.
Fox Bets Big on Stars Group Partnership
Stars Group is pursuing a new partnership that includes joint development of a sports-gambling app with Fox Branding. Stars and Fox essentially signed a 25-year deal in which they expect to launch two apps…
Slack Closes in on IPO
Collaboration tools and services provider Slack Technologies has amended its filing with the SEC for its initial public offering.
Meet One of ASCO’s First Losers
Turning Point Therapeutics shares dipped on Friday after the firm posted interim data for its midstage study in ROS1-positive non-small cell lung cancer patients.